Matrix metalloproteinase-2 (MMP-2) has been used as a target for cancer immunotherapy. The activation of immunization by breaking immune tolerance to self-MMP-2 may be one of the promising approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback